Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Scott T. Reents, Senior Vice President, Chief Financial Officer, has been appointed Executive Vice President, Chief Financial Officer, effective immediately.

On November 28, 2022, Brian L. Durkin, Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2023. Kevin K. Buckbee, 57, has been appointed Senior Vice President, Controller effective March 1, 2023. Mr. Buckbee has been AbbVie's Vice President and Controller, Global Commercial Operations since January 2016. Mr. Buckbee previously served as AbbVie's Vice President and Controller, US Commercial Operations from AbbVie's separation from Abbott Laboratories in 2013 until December 2015. Mr. Buckbee joined Abbott Laboratories in 1991 and held several positions in the finance organization.

© Edgar Online, source Glimpses